226
views
0
recommends
+1 Recommend
2 collections
    1
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      From repurposing to business through successful collaborations

      Published
      proceedings-article
      1
      ScienceOpen
      RExPO22
      2-3 September, 2022
      Drug repurposing, multi party collaborations, Intellectual Property, IP Agreements
      Bookmark

            Abstract

            In recent decades drug repurposing has grown in popularity and has gained even more attention after the FDA gave emergency authorization to several repurposed drugs for the treatment of Covid-19.However, in addition to the successes in drug repurposing there are also failures, and experts from both industry and academia are divided on whether drug repurposing can work as a systematic and profitable business model.Despite these different views, there is in general consensus about that multi parti collaborations, such as between pharmaceutical companies, academic institutions and non-profit organizations, work as a facilitator for drug repurposing.A recent publication1 provides a detailed overview of what in the literature is described as barriers for such collaborative initiatives. Some of these barriers will be looked at in the context of the business development-related objectives as formulated withing the REPO4EU Horizon Europe project, to see and discuss what might be required and what tools could be developed within the REPO4EU Horizon Europe project, to smoothen the path for successful collaborations between the relevant stakeholders in the drug repurposing field.

            Content

            Author and article information

            Conference
            ScienceOpen
            26 August 2022
            Affiliations
            [1 ] IPSIS PACTIS part of Händer and Hjärna AB, Tingsryd (Sweden)
            Article
            10.14293/S2199-rexpo22009.v1
            85191ba0-1280-453a-bb42-88cbf8f2d836
            The Author

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            RExPO22
            Maastricht, Netherlands
            2-3 September, 2022
            History
            Product

            ScienceOpen


            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Drug repurposing,multi party collaborations,Intellectual Property,IP Agreements

            Comments

            Comment on this article